Announcements
OBI Pharma Inc. to attend 2018 industry forum hosted by Masterlink Securities
1.Date of the event: Sep 5, 2018 2.Time: 14:30:00 CST 3.Location：Masterlink Securities (Address: No.97-11, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City 106, Taiwan) 4.Summary: OBI Pharma Inc. to …
OBI received notice from patent attorney’s office that product patent for OBI-3424 named “DNA alkylating agents” has been approved by IP Australia
Date of occurrence of the event: Aug 15, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Clarification on the news article by Commercial Times
Date of occurrence of the event: Jul 28, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Investigational Device Exemption (IDE) for the development of Adagloxad Simolenin (OBI-822) was approved by the US Food and Drug Administration (FDA) for its use in OBI-822 Phase III Clinical Trial
Date of occurrence of the event: Jul 27, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC)
Date of occurrence of the event: Jul 7, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Announcement on the board resolution at Annual General Meeting 2018
Date of the shareholders’ meeting: Jun 27, 2018 Important resolutions (1) profit distribution/deficit compensation: the 2017 earning distribution and expense appropriation was recognized Important resolutions (2) amendments of the company …
Amendment on the announcement for 2018 Annual General Meeting (discussion notes)
Date of the board of directors resolution: May 11, 2018 Date for convening the shareholders’ meeting: June 27, 2018 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …
The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle cash-increase of common shares to issue overseas depository receipts
Date of the board of directors resolution: May 11, 2018 Source of capital increase funds: ash-increase of common shares to issue overseas depository receipts Number of shares issued: no more …
The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle private placement of common shares at the Annual General Meeting
Date of the board of directors resolution: May 11, 2018 Types of the private placement: common shares Buyers of the private placement and their relationships with the company: persons stipulated …
Amendment on the announcement for 2018 Annual General Meeting
Date of the board of directors resolution: May 11, 2018 Date for convening the shareholders’ meeting: June 27, 2018 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …